Logo 661 (Ropinirole Hydrochloride Extended-Release 12 mg)
Pill with imprint Logo 661 is Yellow, Elliptical/Oval and has been identified as Ropinirole Hydrochloride Extended-Release 12 mg. It is supplied by Actavis Elizabeth LLC.
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 12 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 661
Ropinirole Hydrochloride Extended-Release
- Imprint
- Logo 661
- Strength
- 12 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Elizabeth LLC
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
castor oil,
hypromelloses,
lactose monohydrate,
magnesium stearate,
maltodextrin,
titanium dioxide,
ferric oxide yellow,
polyethylene glycol,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-3661 | Actavis Pharma, Inc. |
| 42291-0717 | AvKare, Inc. |
Related Images for "Logo 661"
More about ropinirole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (308)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Ropinirole (Advanced Reading)
- Ropinirole Extended-Release Tablets
- Ropinirole Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.